期刊文献+

核因子E2相关因子2在肝癌发生发展及治疗中作用的研究进展 被引量:1

Research progress on role of nuclear factor erythroid 2-related factor 2 in liver cancer occurrence, development and therapy
原文传递
导出
摘要 近年来肝癌发病率逐年上升,其发生与环境因素密切相关。氧化应激是环境性癌症的主要发病机制之一。核因子E2相关因子2(nuclear factor erythroid 2-related factor 2,Nrf2)通过促进下游抗氧化基因及解毒酶基因表达,发挥抗氧化作用,可抑制肝癌发生。但最近的研究证据表明,肝癌中Nrf2处于高活性,且其抗氧化作用对癌细胞同样有保护作用。Nrf2持续活化介导的适应性抗氧化可参与肝癌细胞形成,促进癌症增殖、侵袭、血管形成,且参与肝癌的放化疗耐受性。该文对Nrf2在肝癌发生发展及治疗中的双重作用进行综述。 The incidence of liver cancer is climbing up recently, which is closely related to environmental factors. Oxidative stress is considered as a key mechanism underlying environmental-related cancers. Nuclear factor erythroid 2-related factor 2(Nrf2) is a master regulator in antioxidant defense which acts through its downstream antioxidant genes and detoxifying enzyme genes. Thus Nrf2 fights against liver cancer. However, high activity of Nrf2 in liver cancer is widely observed. Nrf2 may protect cancer cells as well. Persistent Nrf2 activation results in adaptive antioxidant response. This may participate in the initiation,proliferation, invasion and angiopoiesis of liver cancer, and meanwhile influence chemo- and radio-resistance of liver cancer cells. This review updated the dual roles of Nrf2 in liver cancer.
出处 《环境与健康杂志》 CAS 北大核心 2016年第2期178-181,共4页 Journal of Environment and Health
基金 国家自然科学基金(81573187 81302391) 辽宁省高等学校攀登学者支持计划 辽宁省高等学校优秀人才支持计划(LJQ2014090)
关键词 NRF2 肝肿瘤 化疗 放疗 氧化应激 Nrf2 Liver neoplasm Chemotherapy Radiotherapy Oxidative stress
  • 相关文献

参考文献39

  • 1Torre LA, Bray F, Siegel RI, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65:87-108.
  • 2Nauh JC, Rebnuissou S, Zucman RJ. NRF2/KEAP1 and Wnt/beta- catenin in the muhistep process of liver carcinogtmesis in humans anti rats [ J ].Hepatology,2015, 62:677-679.
  • 3Bishayee A,Bhatia D,Thoppil RJ,et al.Pomegranate -mediated chemoprevenlion of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms [J]. Carcinogenesis, 2011, 32:888-896.
  • 4Eaton DL, Sehaupp CM. Of mice, rats, and men activation protect against aflatoxin heptoeareinogenesis [J ]. Cancer Prey Res, 2014, 7:653-657.
  • 5Yi X,Long L,Yang C,et al.Maolai ameliorates diethylnitrosamine- initiated hepatocellular carcinoma formation in mice [J]. PLoS One 2014.9:93599.
  • 6Kitamura Y,Umemura T, Kanki K, et al. Increased susceptibility to hepatocarcinogenicity of Nrf2-deficient mice exposed to 2-amino- 3-methylimidazo[4,5-f]quinoline [J]. Cancer Sci, 2007, 98:19-24.
  • 7Marhenke S, Lamle J, Buitrago-Molina LE, et al. Activation of nuclear factor E2-related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development [J]. Hepatology, 2008, 48:487-496.
  • 8Enomoto A, hoh K, Nagayoshi E, et al. High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expresion of ARE-regulated drug metabolizing enzymes and antioxidant genes [J]. Toxicol Sci, 2001, 59:169-177.
  • 9Meakin PJ, Chowdhry S, Sharma RS, et al. Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance [J]. Mol Cell Biol, 2014, 34: 3305-3320.
  • 10Lamle J, Marhenke S, Borlak J, et al. Nuclear factor-eythroid 2- related factor 2 prevents alcohol-induced fulminant liver injury [ J ]. Gastroenterology, 2008, 134:1159-1168.

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部